three of these approved drugs, the structures of the cyclic peptide bound to their targets were recently solved by X-ray diffraction or cryomicroscopy and they nicely show the perfect shape complementarity between peptide and target which is the basis for the good binding properties
eptifibatide: PDB 7THO,ziconotide: PDB 7MIX, bremelanotide: PDB 7F55